Breaking News
Get 50% Off 0
🏂 Market too hot? These smart stocks are still ice cold >>>
See Undervalued Stocks
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
26.06 0.00    0.00%
07/07 - Closed. Currency in USD
Type:  Equity
Market:  Chile
ISIN:  US7170811035 
  • Volume: 0
  • Bid/Ask: 26.00 / 0.00
  • Day's Range: 26.06 - 26.06
Pfizer 26.06 0.00 0.00%

Pfizer Inc Company Profile

 
Get an in-depth profile of Pfizer Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

81000

Equity Type

ORD

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Contact Information

Address 66 Hudson Boulevard East
New York, 10001-2192
United States
Phone 212 733 2323
Fax -

Top Executives

Name Age Since Title
Charles T. Hagel 77 - Member of Emerging Markets Advisory Board
Shantanu Narayen 59 2013 Lead Independent Director
Albert Bourla 61 2016 Chairman of the Board & CEO
Joseph J. Echevarria 66 2015 Independent Director
Suzanne M. Nora Johnson 66 2007 Independent Director
James C. Smith 63 2014 Independent Director
Scott Gottlieb 50 2019 Independent Director
Daniel R. Littman 72 2018 Independent Director
Ronald E. Blaylock 65 2017 Independent Director
James Robert B. Quincey 60 2020 Independent Director
Mortimer Joseph Buckley 55 2024 Independent Director
Susan J. Hockfield 73 2020 Independent Director
Susan D. Desmond-Hellmann 68 2020 Independent Director
Cyrus Russi Jal Taraporevala 58 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
George Galloway
George Galloway Jul 08, 2025 4:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moderna up almost 9% today.
Bill Oskouee
Bill Oskouee Jul 01, 2025 10:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock finally moving uo
Erman Barlas
WallWolf Jul 01, 2025 10:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it was the time!
steven king
steven king Jun 26, 2025 7:18AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The CEO needs to step down to save this company. Many investors have lost a lot of money over the past few years.
Avelino Oliveira
Avelino Oliveira Jun 24, 2025 12:58PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So this evolution is not very exuberant but reflects a firm and cautious path offering a good buying opportunity.
Avelino Oliveira
Avelino Oliveira Jun 24, 2025 12:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the weak price evolution is partly due to the search for successive consolidations
Cesar Silva
Cesar Silva Jun 18, 2025 9:50AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Market antivax?
Bill Oskouee
Bill Oskouee Jun 10, 2025 9:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I dont know why board of Directors Don’t replace the CEO,
Bill Oskouee
Bill Oskouee Jun 10, 2025 9:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I dont know why board of Directors Don’t replace the CEO, this stock is at 10 year low, what is management doing ?????
steven king
steven king Jun 10, 2025 9:12AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Most of the managers are family members hired by the CEO. So, they don't know how to run a business.
steven king
steven king Jun 10, 2025 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The stock is fine. The only problem is the CEO, who is a greedy trouble maker. He doesn't want Pfizer's stock price to go up.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email